Roivant Sciences Ltd. Warrant
ROIVW
ROIVW was delisted on the 1st of September, 2023.
40 hedge funds and large institutions have $71.8M invested in Roivant Sciences Ltd. Warrant in 2021 Q4 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$4.5M |
| 2 |
AIG
American International Group
New York
|
+$2.77M |
| 3 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$2.15M |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$2.06M |
| 5 |
CC
Centiva Capital
New York
|
+$1.68M |
Top Sellers
ROIVW Hedge Fund Activity: Q4 2021 in Review
40 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences Ltd. Warrant (ROIVW) for Q4 2021, worth a combined $71.8M.
Buyers outnumbered sellers: 40 funds opened new ROIVW positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was LMR Partners, opening a new position worth an estimated $4.5M.
- 40 institutional investors held Roivant Sciences Ltd. Warrant (ROIVW) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $71.8M of Roivant Sciences Ltd. Warrant stock for Q4 2021.
- 40 funds opened new Roivant Sciences Ltd. Warrant positions in Q4 2021 and 0 closed out, a net change of +40 holders.
- The largest Roivant Sciences Ltd. Warrant buyer in Q4 2021 was LMR Partners, an estimated $4.5M added.
Based on aggregated 13F filings for Q4 2021.